References
- Amin M. Antibacterial prophylaxis in urology: a review. Am J Med 1992; 92 (Suppl. 4A): 114S-117S.
- Grabe M. Perioperative antibiotic prophylaxis in urology. Curr Opin Urol 2001; 11 (1): 81–85.
- Capocasale E, Mazzoni MP, Tondo S, D'Errico G. Antimicrobial prophylaxis with ceftriaxone in renal transplan-tation. Prospective study of 170 patients. Chemotherapy 1994; 40 (6): 435-440.
- Larsen EH, Gasser TC, Madsen PO. Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 1986; 13 (4): 591–604.
- Del Rio G, Dalet F, Chechile G. Antimicrobial prophy-laxis in urologic surgery: does it give some benefit. Eur Urol 1993; 24 (3): 305–312.
- Martin C. Antimicrobial prophylaxis in surgery: general concepts and clinical guidelines. Infect Control Hosp Epidemiol 1994; 15 (7): 463–471.
- Brogden RN, Ward A. Ceftriaxone: a reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 1988; 35 (6): 604–645.
- Joynt GM, Lipman J, Gomersall CD, Young RJ, Gin T. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. J Antimicrob Chemother 2001; 47 (4): 421–429.
- Knapp CC, Sierra-Madero J, Washington JA. Antibacterial activities of cefpodoxime, cefixime, and ceftriax-one. Antimicrob Agents Chemother 1988; 32 (12): 1896–1898.
- Bergamini LB, Polk HCJr. Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis. Surg Gynecol Obstet 1989; 168 (3): 283–289.
- Classen DC, Evans R, Pestopkin SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administra-tion of antibiotic and risk of surgical wound infection. N Engl J Med 1992; 326 (5): 281–286.
- Redington J, Ebert SC, Craig WA. Role of antimicrobial pharmacokinetics and pharmacodynamics in surgical prophy-laxis. Rev Infect Dis 1991; 13 (Suppl. 10): 790-799.
- Martin C, Ragni J, Lokiec F, et al. Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery. Antimicrob Agents Chemother 1992; 36 (12): 2804–2807.
- Trautmann KH, Haeffelfinger I. Determination of the cephalosporin RO 13-9904 in plasma, urine and bile by means of ion-pair reversed phase chromatography. J High Resolut Chromatogr 1981; 4: 54–59.
- Freney J, Mongin-Long D, Meugnier H, et al. Diffusion of ceftriaxone in renal parenchyma. Path Biol 1987; 35 (5 Pt 2): 727-729.
- Martin C, Viviand X, Alaya M, et al. Penetration of cef-triaxone (1 or 2 grams intravenously) into mediastinal and car-diac tissues in humans. Antimicrob Agents Chemother 1996; 40 (3): 812–815.
- Martin C, Viviand X, Coffin A, et al. Concentrations of ceftriaxone (1,000 milligrams intravenously) in abdominal tis-sues during open prostatectomy. Antimicrob Agents Chemother 1996; 40 (5): 1311–1313.
- Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A chal-lenge to hospital leadership. JAMA 1996; 275 (3): 234–240.
- Terpstra S, Noordhoek GT, Voesten HG, Hendriks B, Degener JE. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect 1999; 43 (3): 195–202.
- Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resis-tance. Circulation 2000; 101 (25): 2916–2921.
- Grabe M, Forsgren A, Bjork T, Helisten S. Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur J Clin Microbiol 1987; 6 (1): 11–17.